Vietnam receives 500,000 doses of Vero-Cell vaccine from China
VOV.VN - Vietnam received 500,000 doses of Vero-Cell COVID-19 vaccine produced by Sinopharm, China, alongside 502,400 disposable 1-ml syringes on June 20.
The vaccine donation was arranged by the Party Central Committee’s Commission for External Relations, the Foreign Ministry and the Health Ministry, in coordination with the Chinese Embassy in Vietnam.
The Vero Cell vaccine is set to vaccinate Chinese citizens working in Vietnam, Vietnamese who want to go to China for study, work or business, and people who have needs for vaccine, particularly those living in areas bordering China.
It has been listed by the World Health Organization (WHO) as the vaccine to be used in WHO's Emergency Use Listing (EUL) and purchased by the COVAX Program.
The vaccine has been administered to more than 70 nations globally, including Southeast Asian countries such as Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore and Thailand.
More than 450 million doses of Vero-Cell vaccine have been produced, of which 100 million have been provided through government aid, and commercial sales for businesses.
The nation has been using the AstraZeneca vaccine for its vaccination program and has adopted four COVID-19 vaccines so far, namely U.K.'s AstraZeneca, Russia's Generium, China's Sinopharm and a vaccine developed by U.S.-based firm Pfizer and Germany's BioNTech Inc.